Diagnostic performance of non-invasive markers of fibrosis compared with liver biopsy in MASLD patients in tertiary care centre

Authors

  • Mukesh Kumar Senior Resident, Department of Gastroenterology, GMCH, Guwahati, India
  • Bikash Narayan Choudhury Professor, Department of Gastroenterology, GMCH, Guwahati, India
  • Mallika Bhattacharyya Associate Professor, Department of Gastroenterology, GMCH, Guwahati, India
  • Sandeep Saini Senior Resident, Department of Gastroenterology, GMCH, Guwahati, India
  • Usha Sharma Professor, Department of Pathology, GMCH, Guwahati, India
  • U.J Deka Associate Professor, Department of Medicine, GMCH, Guwahati, India
  • B.J Baruah Associate Professor, Department of Gastroenterology, GMCH, Guwahati, India

DOI:

https://doi.org/10.32553/ijmbs.v10i1.3192

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects a significant proportion of the global population, with a subset progressing to advanced fibrosis carrying risks of portal hypertension and hepatocellular carcinoma. Non-invasive tests (NITs) including liver stiffness measurement (LSM), FIB-4, NAFLD Fibrosis Score (NFS), and APRI are increasingly used for fibrosis assessment, yet their diagnostic accuracy varies across populations and phenotypes, including lean MASLD

Downloads

Published

2026-02-27

How to Cite

Kumar, M. ., Choudhury, B. N. ., Bhattacharyya, M. ., Saini, S. ., Sharma, U. ., Deka, U. ., & Baruah, B. . (2026). Diagnostic performance of non-invasive markers of fibrosis compared with liver biopsy in MASLD patients in tertiary care centre. International Journal of Medical and Biomedical Studies, 10(1), 32–44. https://doi.org/10.32553/ijmbs.v10i1.3192

Issue

Vol. 10 No. 1 (2026)

Section

Articles

License

Copyright (c) 2026 International Journal of Medical and Biomedical Studies

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.